Histopathologic and genetic alterations as predictors of response to treatment and survival in lung cancer: a review of published data.

Histopathologic and genetic alterations as predictors of response to treatment and survival in lung cancer: a review of published data.

Item
http://www.wikidata.org/entity/Q33515966
Balance between MKK6 and MKK3 mediates p38 MAPK associated resistance to cisplatin in NSCLCComputer-aided diagnosis for early-stage lung cancer based on longitudinal and balanced data.Common genetic variants in cell cycle pathway are associated with survival in stage III-IV non-small-cell lung cancerExpression profiling of receptor tyrosine kinases in high-grade neuroendocrine carcinoma of the lung: a comparative analysis with adenocarcinoma and squamous cell carcinomaLong non-coding RNA TUG1 is involved in cell growth and chemoresistance of small cell lung cancer by regulating LIMK2b via EZH2.Contrasting responses of non-small cell lung cancer to antiangiogenic therapies depend on histological subtypeA benefit-risk assessment of erlotinib in non-small-cell lung cancer and pancreatic cancer.Validation of cofilin-1 as a biomarker in non-small cell lung cancer: application of quantitative method in a retrospective cohort.Advances in EGFR as a Predictive Marker in Lung Adenocarcinoma.MKP1 mediates chemosensitizer effects of E1a in response to cisplatin in non-small cell lung carcinoma cells.In vitro evaluation of antitumoral efficacy of catalase in combination with traditional chemotherapeutic drugs against human lung adenocarcinoma cells.Specific Biomarkers Are Associated with Docetaxeland Gemcitabine-Resistant NSCLC Cell Lines.The relationship between EGFR gain and VHL loss in lung adenocarcinoma and poor patient survival.Evaluation of Detection Methods and Values of Circulating Vascular Endothelial Growth Factor in Lung Cancer.Time since start of first-line therapy as a predictive clinical marker for nintedanib in patients with previously treated non-small cell lung cancer.[Research advance on non-small cell lung carcinoma with neuroendocrine differentiation].[Long-term survival of personalized surgical treatment of locally advanced non-small cell lung cancer based on molecular staging].
P2860

Histopathologic and genetic alterations as predictors of response to treatment and survival in lung cancer: a review of published data.

Item
http://www.wikidata.org/entity/Q33515966
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Histopathologic and genetic al ...... r: a review of published data.
@ast
Histopathologic and genetic al ...... r: a review of published data.
@en
Histopathologic and genetic al ...... r: a review of published data.
@nl
type
label
Histopathologic and genetic al ...... r: a review of published data.
@ast
Histopathologic and genetic al ...... r: a review of published data.
@en
Histopathologic and genetic al ...... r: a review of published data.
@nl
prefLabel
Histopathologic and genetic al ...... r: a review of published data.
@ast
Histopathologic and genetic al ...... r: a review of published data.
@en
Histopathologic and genetic al ...... r: a review of published data.
@nl
P1433
P1476
P2093
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P356
P1433
P1476
Histopathologic and genetic al ...... r: a review of published data.
@en
P2093
P304
P31
P356
10.1016/J.CRITREVONC.2009.10.002
P433
P478
P50
P577
P5875
P698